Unichem Laboratories Ltd (UNICHEMLAB):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Unichem Laboratories Ltd (UNICHEMLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3342
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unichem Laboratories Ltd (Unichem) is an integrated, specialty pharmaceutical company which manufactures pharmaceutical formulations, generic products and active pharmaceutical ingredients (API’s). The company offers its products in the therapeutic areas of gastroenterology, anti-invectives, anti-bacterial, diabetology, psychiatry, cardiology, central nervous system, neurology and pain management, among others. Its product portfolio includes alfuzosin hydrochloride, aripiprazole, cetirizine hydrochloride, glipizide, meloxicam, paliperidone, quetiapine fumarate, apixaban, apremilast and solifenacin succinate. Unichem also provides product development, process chemistry and manufacturing of complex API as well as dosage forms from samples and trial quantities for regulatory assistance. The company conducts research and development activities to develop chemical processes for APIs and contract formulations for generic companies. It operates business activities in Americas, ACASIA and European Union. Unichem is headquartered in Mumbai, Maharashtra, India.

Unichem Laboratories Ltd (UNICHEMLAB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Unichem Labs Acquires API Manufacturing Plant at Kolhapur 9
Asset Transactions 10
Torrent Pharma Acquires Branded Business from Unichem Labs for USD556.6 Million 10
Mylan Completes Acquisition Of Drug Manufacturing Plant From Unichem For US$30 Million 12
Unichem Laboratories Ltd – Key Competitors 13
Unichem Laboratories Ltd – Key Employees 14
Unichem Laboratories Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 17
Legal and Regulatory 17
Aug 01, 2018: Unichem Laboratories Announces Successful US FDA inspection of API manufacturing facility at Pithampur, Madhya Pradesh 17
Jun 06, 2018: Unichem Laboratories Announces Update on USFDA Inspection 18
Jun 06, 2018: Unichem’s formulation manufacturing facility at Ghaziabad Receives Establishment Inspection Report (EIR) from USFDA 19
Apr 20, 2018: Unichem Laboratories Completed USFDA Inspection for its Manufacturing Facility at Ghaziabad 20
Jun 30, 2017: Unichem Laboratories receives of Establishment Inspection Report from the United States Food And Drug Administration for its Goa Formulation plant 21
Jun 07, 2017: Unichem Laboratories Receives of Establishment Inspection Report From The united States Food and Drug Administration 22
Mar 20, 2017: Unichem Laboratories Successfully completed Inspection by USFDA for its manufacturing facility at Goa 23
Mar 06, 2017: Unichem Laboratories Successfully completed Inspection by USFDA for its manufacturing facility at Ghaziabad 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Unichem Labs Acquires API Manufacturing Plant at Kolhapur 9
Torrent Pharma Acquires Branded Business from Unichem Labs for USD556.6 Million 10
Mylan Completes Acquisition Of Drug Manufacturing Plant From Unichem For US$30 Million 12
Unichem Laboratories Ltd, Key Competitors 13
Unichem Laboratories Ltd, Key Employees 14
Unichem Laboratories Ltd, Other Locations 15
Unichem Laboratories Ltd, Subsidiaries 15

List of Figures
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Unichem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Unichem Laboratories Ltd (UNICHEMLAB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avisa Pharma Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company provides product such as avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic di …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Vivendi SA (VIV):企業の財務・戦略的SWOT分析
    Vivendi SA (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Gevo Inc (GEVO):企業の財務・戦略的SWOT分析
    Summary Gevo Inc (Gevo) is a renewable chemicals and advanced biofuels company that offers renewable chemicals and biofuels. The company’s products include carbon cycle products, low carbon renewable jet fuels, renewable gasoline, isobutanol blendstocks, ingredient products, animal feed and proteins …
  • Broadcom Inc:企業の戦略・SWOT・財務情報
    Broadcom Inc - Strategy, SWOT and Corporate Finance Report Summary Broadcom Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • DXI Energy Inc (DXI):石油・ガス:M&Aディール及び事業提携情報
    Summary DXI Energy Inc (DXI Energy), formerly Dejour Energy Inc is an upstream oil and gas company. The company undertakes the business of oil and gas exploration, distribution and production. It explores for oil and gas properties in regions of Colorado and British Columbia. DXI Energy operates pro …
  • Welspun Corp Ltd:企業の戦略・SWOT・財務情報
    Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Seair, Inc. (SDS)-石油・ガス分野:企業M&A・提携分析
    Summary Seair, Inc. (Seair) is a clean technology company that carries out research and development, production and sale of diffusion and sterilization technologies. It focuses on commercializing advanced waste water and industrial fluid treatment solutions. The company offers high performance propr …
  • Grupo SATA:企業の戦略的SWOT分析
    Grupo SATA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Korea Development Bank:企業の戦略・SWOT・財務情報
    Korea Development Bank - Strategy, SWOT and Corporate Finance Report Summary Korea Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報
    Summary Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and bi …
  • Ontario Municipal Employees Retirement System:電力:M&Aディール及び事業提携情報
    Summary Ontario Municipal Employees Retirement System (OMERS) offers pension benefits to government employees, beneficiaries, and retirees from diverse sectors such as municipalities, libraries, police and fire departments, schools, and other agencies in Ontario. It is sponsored by OMERS Sponsors Co …
  • Widex AS:企業の戦略的SWOT分析
    Widex AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Kyushu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • NV Energy Inc:企業の戦略的SWOT分析
    NV Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Sunrun Inc (RUN):企業の財務・戦略的SWOT分析
    Sunrun Inc (RUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Unity Bank Plc:企業の戦略・SWOT・財務情報
    Unity Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Unity Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • TAT Technologies, Ltd.:企業の戦略・SWOT・財務分析
    TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bharti Airtel Limited:企業の戦略・SWOT・財務情報
    Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report Summary Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Beacon Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Beacon Biomedical Inc (Beacon) is a medical diagnostic device company that offers point-of-care blood test systems. The company offers its product portfolio in the therapeutic areas of breast cancer, colorectal cancer and lung cancer. It holds two patented technologies such as signaling prot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆